Nanobiotix Shares Fall 6.13% Midday After Recent Surge
The French biotech takes a breather this Tuesday after a spectacular rise of over 400% in three months.
Current Trading Session
The stock is down 6.13% at 22.95 euros at midday, following a 9.15% increase the previous day that had pushed it to 24.45 euros. This correction comes amid a remarkable progression in recent weeks, with a gain of 23.92% over seven days and a surge of 415.7% over three months. Since the beginning of the year, the stock has increased more than sevenfold, showing a performance of 419%, significantly outperforming the CAC 40, which has risen by 3.75% over the year. Trading volumes remain moderate with 0.59% of the capital traded in the morning, while the Paris index itself is down 0.91% at 7,862 points.
Technical Indicators
The Relative Strength Index, which measures the speed and magnitude of price changes, stands at 87, an exceptionally high level indicating a marked overbought condition. Above 70, this indicator generally suggests a short-term overheating of the stock, which may explain the profit-taking observed this morning. However, the stock price remains well above its 50-day moving average, set at 10.61 euros, and its 200-day average, positioned at 5.39 euros, confirming the solidity of the underlying bullish trend. The MACD, an indicator that helps identify momentum shifts, remains positive with a main line at 3.73 above its signal line at 2.84, indicating that the bullish momentum is not yet questioned despite today's decline.
Volatility and Technical Resistance
The monthly volatility of the stock is established at 34.74%, a high level reflecting the significant amplitude of recent price movements. This high volatility contrasts with a beta of only 0.32, indicating that Nanobiotix reacts much less than proportionally to variations in the CAC 40. The technical resistance now stands at 24.45 euros, the peak reached yesterday, while the support remains distant at 7.20 euros. The Bollinger Bands, which measure volatility and define extreme price zones, currently frame movements between 5.81 euros and 25.18 euros, placing the current price in the upper part of this range. This setup confirms that the stock is trading near its upper boundary, consistent with the overbought signal.
